{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:44Z","timestamp":1772165684095,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sanming Project of Medicine in Shenzhen Municipality","award":["SZSM202311032"],"award-info":[{"award-number":["SZSM202311032"]}]},{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["SZXK070"],"award-info":[{"award-number":["SZXK070"]}]},{"name":"Vertical research project of General Universal Medical Group","award":["UM0223003"],"award-info":[{"award-number":["UM0223003"]}]},{"name":"Vertical research project of General Universal Medical Group","award":["UM0223002"],"award-info":[{"award-number":["UM0223002"]}]},{"name":"Medical research project of Xi\u2019an Science and Technology Bureau","award":["24YXYJ0180"],"award-info":[{"award-number":["24YXYJ0180"]}]},{"name":"Qin Chuangyuan recruited high-level innovation and entrepreneurship talents project of Science and Technology Department of Shanxi Province","award":["QCYRCXM-2022-56"],"award-info":[{"award-number":["QCYRCXM-2022-56"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12077-w","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:17:26Z","timestamp":1764332246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A preliminary survey on the use of ART among blood donors in Shenzhen China and its implications to blood safety"],"prefix":"10.1186","volume":"25","author":[{"given":"Lilin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingnan","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jujun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenze","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"12077_CR1","doi-asserted-by":"crossref","unstructured":"Massud I, Nishiura K, Ruone S et al. Weekly oral tenofovir alafenamide protects macaques from vaginal and rectal simian HIV infection. Pharmaceutics. 2024;16(3).","DOI":"10.3390\/pharmaceutics16030384"},{"issue":"12","key":"12077_CR2","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/S2352-3018(23)00261-8","volume":"10","author":"RJ Landovitz","year":"2023","unstructured":"Landovitz RJ, Hanscom BS, Clement ME, et al. Efficacy and safety of long-acting cabotegravir compared with daily oral Tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023;10(12):e767\u201378.","journal-title":"Lancet HIV"},{"issue":"8","key":"12077_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2023.9865","volume":"330","author":"R Chou","year":"2023","unstructured":"Chou R, Spencer H, Bougatsos C, Blazina I, Ahmed A, Selph S. Preexposure prophylaxis for the prevention of HIV: updated evidence report and systematic review for the US preventive services task force. JAMA. 2023;330(8):746\u201363.","journal-title":"JAMA"},{"issue":"5","key":"12077_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"key":"12077_CR5","doi-asserted-by":"crossref","unstructured":"Moschese D, Lazzarin S, Colombo ML, et al. Breakthrough acute HIV infections among pre-exposure prophylaxis users with high adherence: a narrative review. Viruses. 2024;16(6).","DOI":"10.3390\/v16060951"},{"issue":"1","key":"12077_CR6","doi-asserted-by":"publisher","first-page":"e068792","DOI":"10.1136\/bmjopen-2022-068792","volume":"13","author":"H Berihun","year":"2023","unstructured":"Berihun H, Bazie GW, Beyene A, Zewdie A, Kebede N. Viral suppression and associated factors among children tested for HIV viral load at Amhara public health Institute, Dessie Branch, ethiopia: a cross-sectional study. BMJ Open. 2023;13(1):e068792.","journal-title":"BMJ Open"},{"issue":"9396","key":"12077_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","volume":"362","author":"D Dunn","year":"2003","unstructured":"Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or Zidovudine monotherapy: a meta-analysis. Lancet (London England). 2003;362(9396):1605\u201311.","journal-title":"Lancet (London England)"},{"key":"12077_CR8","doi-asserted-by":"crossref","unstructured":"Manak MM, Jagodzinski LL, Shutt A, et al. Decreased seroreactivity in individuals initiating antiretroviral therapy during acute HIV infection. J Clin Microbiol. 2019;57(10).","DOI":"10.1128\/JCM.00757-19"},{"issue":"1","key":"12077_CR9","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2352-3018(17)30146-7","volume":"5","author":"KL Dong","year":"2018","unstructured":"Dong KL, Moodley A, Kwon DS, et al. Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South africa: a prospective cohort study. Lancet HIV. 2018;5(1):e35\u201344.","journal-title":"Lancet HIV"},{"issue":"5","key":"12077_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/500215","volume":"42","author":"CB Hare","year":"2006","unstructured":"Hare CB, Pappalardo BL, Busch MP, et al. Seroreversion in subjects receiving antiretroviral therapy during acute\/early HIV infection. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;42(5):700\u20138.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"6","key":"12077_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1086\/428127","volume":"40","author":"S Kassutto","year":"2005","unstructured":"Kassutto S, Johnston MN, Rosenberg ES. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2005;40(6):868\u201373.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"11","key":"12077_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1182\/blood.2020006890","volume":"136","author":"B Custer","year":"2020","unstructured":"Custer B, Quiner C, Haaland R, et al. HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern. Blood. 2020;136(11):1351\u20138.","journal-title":"Blood"},{"key":"12077_CR13","doi-asserted-by":"crossref","unstructured":"Maddox V, Reynolds C, Amara A, et al. Undeclared pre-exposure or post-exposure prophylaxis (PrEP\/PEP) use among syphilis-positive blood donors, England, 2020 to 2021. Euro Surveillance: bulletin europ\u00e9en Sur les maladies transmissibles\u2009=\u2009European communicable disease bulletin. 2023;28(11).","DOI":"10.2807\/1560-7917.ES.2023.28.11.2300135"},{"issue":"2","key":"12077_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/sextrans-2021-054981","volume":"98","author":"H Harvala","year":"2022","unstructured":"Harvala H, Reynolds C, Ijaz S, et al. Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP\/PEP) among blood donors: a pilot study, England June 2018 to July 2019. Sex Transm Infect. 2022;98(2):132\u20135.","journal-title":"Sex Transm Infect"},{"issue":"8","key":"12077_CR15","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1111\/trf.16571","volume":"61","author":"K van den Berg","year":"2021","unstructured":"van den Berg K, Vermeulen M, Louw VJ, Murphy EL, Maartens G. Undisclosed HIV status and antiretroviral therapy use among South African blood donors. Transfusion. 2021;61(8):2392\u2013400.","journal-title":"Transfusion"},{"issue":"11","key":"12077_CR16","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1111\/trf.15515","volume":"59","author":"Y Yu","year":"2019","unstructured":"Yu Y, Xu J, Li M. Prevalence of HIV infection among Chinese voluntary blood donors during 2010\u20132017: an updated systematic review and meta-analysis. Transfusion. 2019;59(11):3431\u201341.","journal-title":"Transfusion"},{"issue":"1","key":"12077_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/trf.15636","volume":"60","author":"L Shi","year":"2020","unstructured":"Shi L, Liu Y, Wang J, et al. HIV prevalence and incidence estimates among blood donors in five regions in China. Transfusion. 2020;60(1):117\u201325.","journal-title":"Transfusion"},{"issue":"12","key":"12077_CR18","first-page":"1490","volume":"28","author":"YL Lv","year":"2015","unstructured":"Lv YL, Jiao XF. Analysis of HIV infection in MSM population of voluntary blood donors in Zhengzhou. China J Blood Transfus. 2015;28(12):1490\u20132.","journal-title":"China J Blood Transfus"},{"issue":"1","key":"12077_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0956462418781142","volume":"30","author":"ZW Zheng","year":"2019","unstructured":"Zheng ZW, Qiu JL, Gu J, Xu HF, Cheng WB, Hao C. Preexposure prophylaxis comprehension and the certainty of willingness to use preexposure prophylaxis among men who have sex with men in China. Int J STD AIDS. 2019;30(1):4\u201311.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"12077_CR20","doi-asserted-by":"publisher","first-page":"e25242","DOI":"10.1002\/jia2.25242","volume":"22","author":"J Han","year":"2019","unstructured":"Han J, Bouey JZ, Wang L, et al. PrEP uptake preferences among men who have sex with men in china: results from a National internet survey. J Int AIDS Soc. 2019;22(2):e25242.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"12077_CR21","doi-asserted-by":"publisher","first-page":"103848","DOI":"10.1016\/j.bjid.2024.103848","volume":"28","author":"MIS Souza","year":"2024","unstructured":"Souza MIS, Crispim MAE, Fraiji NA, Silva-Junior AL, Stefani MMA. HIV acute infection and long-term undisclosed HIV status among blood donors from the highly endemic Amazonas state, located in the Brazilian Amazon. Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis. 2024;28(4):103848.","journal-title":"Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis"},{"issue":"4","key":"12077_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/tme.12957","volume":"33","author":"K van den Berg","year":"2023","unstructured":"van den Berg K, Murphy EL, Louw VJ, Maartens G, Hughes SD. Motivations for blood donation by HIV-positive individuals on antiretrovirals in South africa: A qualitative study. Transfus Med. 2023;33(4):277\u201386.","journal-title":"Transfus Med"},{"issue":"28","key":"12077_CR23","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1021\/acs.analchem.2c00553","volume":"94","author":"Y Barekatain","year":"2022","unstructured":"Barekatain Y, Khadka S, Harris K, et al. Quantification of phosphonate drugs by (1) H-(31) P HSQC shows that rats are better models of primate drug exposure than mice. Anal Chem. 2022;94(28):10045\u201353.","journal-title":"Anal Chem"},{"issue":"20","key":"12077_CR24","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1002\/jssc.202200332","volume":"45","author":"RM Abdelfatah","year":"2022","unstructured":"Abdelfatah RM, Abdelaleem EA, Abdelmomen EH, Abdelmoety RH, Emam AA. Sensitive and selective Bioscreening of the most commonly used coronavirus disease drug, Favipiravir, and its co-administered therapeutic, Meropenem, in human plasma. J Sep Sci. 2022;45(20):3800\u201310.","journal-title":"J Sep Sci"},{"key":"12077_CR25","doi-asserted-by":"crossref","unstructured":"Eron J, Hung CC, Baril JG, et al. Brief report: virologic response by baseline viral load with dolutegravir plus lamivudine vs dolutegravir plus tenofovir disoproxil fumarate\/emtricitabine: pooled analysis. J Acquir Immune Defic Syndr (1999). 2020;84(1):60\u201365.","DOI":"10.1097\/QAI.0000000000002302"},{"issue":"11","key":"12077_CR26","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/trf.17544","volume":"63","author":"A Nishiya","year":"2023","unstructured":"Nishiya A, Salles N, de Almeida-Neto C, et al. Detection of unreported usage of the antiretroviral drug lamivudine in two blood donors. Transfusion. 2023;63(11):2106\u201313.","journal-title":"Transfusion"},{"key":"12077_CR27","doi-asserted-by":"crossref","unstructured":"Mitchell JL, Pollara J, Dietze K, et al. Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection. J Clin Investig. 2022;132(1).","DOI":"10.1172\/JCI150937"},{"issue":"7","key":"12077_CR28","doi-asserted-by":"publisher","first-page":"ofac259","DOI":"10.1093\/ofid\/ofac259","volume":"9","author":"J Zucker","year":"2022","unstructured":"Zucker J, Carnevale C, Gordon P, Sobieszczyk ME, Rai AJ. Am I positive? Improving human immunodeficiency virus testing in the era of preexposure prophylaxis and immediate antiretroviral therapy using machine learning. Open Forum Infect Dis. 2022;9(7):ofac259.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"12077_CR29","doi-asserted-by":"publisher","first-page":"e25461","DOI":"10.1002\/jia2.25461","volume":"23","author":"PS Sullivan","year":"2020","unstructured":"Sullivan PS, Sanchez TH, Zlotorzynska M, et al. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among united States men who have sex with men recruited online, 2013 through 2017. J Int AIDS Soc. 2020;23(3):e25461.","journal-title":"J Int AIDS Soc"},{"key":"12077_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-11-7","volume":"11","author":"K Duri","year":"2011","unstructured":"Duri K, M\u00fcller F, Gumbo FZ, et al. Human immunodeficiency virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy na\u00efve pregnant women in Harare, Zimbabwe. BMC Infect Dis. 2011;11:7.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"12077_CR31","doi-asserted-by":"publisher","first-page":"e0305935","DOI":"10.1371\/journal.pone.0305935","volume":"19","author":"C Mangala","year":"2024","unstructured":"Mangala C, Takou D, Maulot-Bangola D, et al. HIV-1 residual risk and pre-treatment drug resistance among blood donors: A Sentinel surveillance from Gabon. PLoS ONE. 2024;19(9):e0305935.","journal-title":"PLoS ONE"},{"issue":"1","key":"12077_CR32","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.1038\/s41598-020-64463-w","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Lv X, Chang L, et al. HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-na\u00efve blood donors in China. Sci Rep. 2020;10(1):7571.","journal-title":"Sci Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12077-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:17:27Z","timestamp":1764332247000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-12077-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12077"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12077-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6615754\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki standard, and has been approved by the Ethics Committee of Shenzhen Blood Center (approval number SZBCMEC-2021-009). Informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1673"}}